LEXINGTON, Mass.--(BUSINESS WIRE)--Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to treat severe medical conditions, today announced that the Company will be presenting at the R.W. Baird Healthcare Conference on Thursday, September 10 at 1:45 p.m. (ET) at the Four Seasons Hotel New York.
